Financing life sciences on both sides of the border

Life sciences have taken on increased importance in recent months, and are sure to be a significant part of Canada’s post-pandemic economy. Join us for our five-part webinar series that will discuss the latest legal and regulatory developments at all stages of the sector’s complex life cycle.

The pandemic has been a turning point for investment in life sciences. What does this mean for investors as well as life sciences companies looking to find opportunity in the industry? In the final webinar of our series, our corporate and capital markets lawyers from Toronto, New York and Calgary—Cheryl Reicin, Chris Bornhorst and Mike Pedlow—unpack the current state of financing for life science companies. The panel will discuss seed investments, venture capital, and public offerings both from Canadian and U.S. perspectives.

9:00 a.m. Webinar opens
9:15 - 10:15 a.m. Presentation

Ontario: This program is eligible for up to 1.0 Substantive hour.
New York: This program contains 1.0 Areas of Professional Practice Credit.

Click here to register.

Sessions in this series:

• Navigating (and challenging) a changing life sciences regulatory environment
• Life sciences product liability litigation: managing risks and anticipating trends
• The latest developments in life sciences IP litigation
• Life sciences and centralized procurement: navigating the process and responding to RFPs
• Financing life sciences on both sides of the border